Spark signs gene therapy licensing deal valued at up to $328.5M
October 12, 2021 at 10:22 AM EDT
The agreement includes exclusive rights to an experimental gene therapy for epilepsy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|